Thursday’s Top Medical & Biotech Stocks

By admin | February 29, 2008

Submitted by BioHealth Investor Blog

by H.S. Ayoub
BioHealth Investor

Subscribe now to keep up to date on the latest news, articles and daily top stocks:

Subscribe by Email
Subscribe by Feed

Biotechnology

TRANSDEL PHARMACTL [TDLP.OB] +25.00%
OCTILLION CORP NEW [OCTL.OB] +21.09%
EXACT SCIENCES COR [EXAS] +20.32%
BARRIER THERAPEUTICS [BTRX] +9.88%
GPC BIOTECH AG [GPCB] +8.87%

Diagnostic Substances

HUMAN GENOME SCI [HGSI] +8.85%
IMMUNOMEDICS INC [IMMU] +4.18%
SCOLR PHARMA INC [DDD] +3.85%
AVALON PHARMACEUTIC [AVRX] +3.60%
ASPENBIO PHARMA INC [APPY] +2.44%

Drug Delivery

NEKTAR THERAPEUTIC [NKTR] +10.37%
HOSPIRA INC [HSP] +7.57%
BIOVAIL CORP [BVF] +5.75%
ELAN CP PLC ADR [ELN] +3.29%
ULURU INC [ULU] +2.42%

Drug Manufacturers

KERYX BIOPHARM INC [KERX] +19.92%
SPECTRUM PHARMA INC [SPPI] +13.92%
MARSHALL EDWARDS [MSHL] +12.08%
MIDDLEBROOK PHARMACL [MBRK] +10.26%
ARYX THERAPEUTICS, I [ARYX] +9.46%

Drug Related Products

MANNATECH INC [MTEX] +8.38%
INTEGRATED BIOPHARMA [INBP] +4.11%
ARGAN INC [AGX] +0.86%
TIENS BIOTECH GR USA [TBV] +0.48%
USANA HEALTH SCIEN [USNA] +0.31%

Generic Drugs

CATALYST PHARMACEUTI [CPRX] +8.70%

Medical Appliances & Equipment

RESTORE MEDICAL INC [REST] +12.87%
CONSORTIUM SVC MGT [CTUM.OB] +12.75%
ATS MEDICAL INC [ATSI] +10.65%
UROLOGIX INC [ULGX] +6.86%
[MAKO] +6.66%

Medical Instruments & Supplies

EP MEDSYSTEMS INC [EPMD] +6.43%
CARDIAC SCIENCE CORP [CSCX] +5.74%
ENCISION INC [ECI] +5.00%
CPC OF AMERICA INC [CPCF.OB] +4.76%
IMPLANT SCIENCES CP [IMX] +2.21%

Medical Laboratories & Research

ERESEARCHTECHNOLOG [ERES] +4.99%
PHARM PROD DEV [PPDI] +0.97%
ENZO BIOCHEM INC [ENZ] +0.94%
ARRAY BIOPHARMA IN [ARRY] +0.36%

- Wednesday’s Top Biotech & Medical Stocks
- Tuesday’s Top Biotech & Medical Stocks

Rating 3.00 out of 5
[?]

We don't know every stock and we want to know your thoughts. Register on Biotech Stocks Blog now and get published within minutes. Before posting, it is recommended that you review our posting guidelines.

Comments